November 18, 2025
Calendar
1:30pm - 2:30pm
GMT
Why join us?
With the emergence of new diagnostic tools, blood-based biomarkers, and disease-modifying therapies, Alzheimer’s disease management is rapidly evolving, driving the need for earlier detection and more effective care pathways. This webinar will explore what these changes mean for clinical practice, highlight innovations already in development, and address the real-world barriers to implementation.
Our panel features leading experts across the Alzheimer’s ecosystem - including specialists in dementia trials, primary care integration, AI-powered risk screening, and clinical outcomes assessments.
Join us to gain actionable insights on risk stratification, practical implementation of new diagnostics, and collaborative approaches that can accelerate readiness for disease-modifying therapies, whether you work in medical affairs, RWE, HEOR, epidemiology, safety, commercial strategy, market access, or patient advocacy.
Key Learning Objectives
Access broad and deep neurology expertise to reduce costs, accelerate timelines and manage risk, from clinical trials to evidence generation and beyond.
.svg){kind=icon}
